Company / Shareholders' Equity
Avantor Shareholders' Equity History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$5.6B
FY2025
5-year range
$2.7B / $6.0B
FY2021-FY2025
Trend
-6.6%
vs FY2024
Sector context
#30 of 161
Health Care
What the data says
Avantor's shareholders' equity of $5.6B is higher than 81% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 9 years, ranging from -$3.1B in FY2018 to $6.0B in FY2024.
Based on SEC 10-K filings.
$5.6B in FY2025 with a 5-year CAGR of +15.8%. Top quartile in the Health Care sector.
Improved from $5.3B to $5.6B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +27.7%
- 5-Year CAGR
- +15.8%
- 10-Year CAGR
- -
Sector benchmark
+9.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +15.8%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 6.6% year-over-year.
- Ranks #30 out of 161 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.6B | -6.6% |
| FY2024 | $6.0B | +13.4% |
| FY2023 | $5.3B | +96.4% |
| FY2022 | $2.7B | -36.3% |
| FY2021 | $4.2B | +56.9% |
| FY2020 | $2.7B | +202.1% |
| FY2019 | -$2.6B | +14.1% |
| FY2018 | -$3.1B | -16.5% |
| FY2017 | -$2.6B | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026